Genetic Veterinary Sciences v. Laboklin GmbH & Co. KG, No. 18-2056 (Fed. Cir. July 29, 2019)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Appellee Genetic Veterinary Sciences, Inc. , d/b/a Paw Prints Genetics (“ PPG”) sued Appellants LABOKLIN GmbH & Co. KG (“LABOKLIN”) and the University of Bern (“the University”) (together, “Appellants”) in the U.S. District Court for the Eastern District of Virginia (“District Court”), seeking a declaratory judgment that claims 1−3 (“Asserted Claims”) of the University ’s U.S. Patent No. 9,157,114 (“the ’114 patent”) are patent-ineligible under 35 U.S.C. § 101 (2012).1 J.A. 50−57 (Complaint).